Keros Therapeutics Inc (KROS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 0 | 0 | 0 | 2,500 | 2,500 |
| Gross Profit | N/A | N/A | N/A | 2,500 | 2,500 |
| Operating Expenses | 11,948 | 10,914 | 10,504 | 5,228 | 4,826 |
| Operating Income | -11,948 | -10,914 | -10,504 | -2,728 | -2,326 |
| Interest Expense | 2 | 1 | 2 | 1 | 3 |
| Other Income | -86 | 158 | -1,558 | -22 | -1,220 |
| Pre-tax Income | -12,036 | -10,757 | -12,064 | -2,751 | -3,549 |
| Income Tax | N/A | N/A | -172 | 0 | N/A |
| Net Income Continuous | -12,036 | -10,757 | -11,892 | -2,751 | -3,549 |
| Net Income | $-12,036 | $-10,757 | $-11,892 | $-2,751 | $-3,549 |
| EPS Basic Total Ops | -0.60 | -0.62 | -5.11 | -1.32 | -1.71 |
| EPS Basic Continuous Ops | -0.60 | -0.61 | -4.79 | -1.13 | -1.51 |
| EPS Diluted Total Ops | -0.60 | -0.62 | -5.11 | -1.32 | -1.71 |
| EPS Diluted Continuous Ops | -0.60 | -0.61 | -4.79 | -1.13 | -1.51 |
| EBITDA(a) | $-11,876 | $-10,846 | $-10,441 | $-2,669 | $-2,271 |